Benefit of intravenously administered immune serum globulin in patients with Guillain-Barré syndrome
- 1 January 1990
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 116 (1) , 141-144
- https://doi.org/10.1016/s0022-3476(05)81667-1
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Reversal of Chronic Polymyositis Following Intravenous Immune Serum Globulin TherapyJAMA, 1987
- The Utility of Therapeutic Plasmapheresis for Neurological DisordersPublished by American Medical Association (AMA) ,1986
- Acute and Chronic Demyelinating Inflammatory PolyradiculoneuropathyArchives of Neurology, 1986
- Clinical correlation with anti‐peripheral‐nerve myelin antibodies in Guillain‐Barré syndromeAnnals of Neurology, 1986
- Plasmapheresis in the treatment of the Guillain-Barré syndrome in childhoodPediatric Neurology, 1985
- Plasmapheresis and acute Guillain‐Barre syndromeNeurology, 1985
- Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation.Proceedings of the National Academy of Sciences, 1985
- Demyelination induced by serum form patients with Guillain‐Barré syndromeAnnals of Neurology, 1984
- Electrophysiological studies in the Guillain-Barré syndromeAnnals of Neurology, 1981
- Guillain-Barré syndrome: Demonstration of antibodies to peripheral nerve tissueActa Neurologica Scandinavica, 1978